The Urgent Need for Molecular Imaging to Confirm Target Engagement for Clinical Trials of Fragile X Syndrome and Other Subtypes of Autism Spectrum Disorder
Author(s) -
James Robert Bras̆ić,
Anil Mathur,
Dejan B. Budimirovic
Publication year - 2019
Publication title -
archives of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.116
H-Index - 3
eISSN - 2322-5769
pISSN - 2322-3944
DOI - 10.5812/ans.91831
Subject(s) - fragile x syndrome , clinical trial , autism spectrum disorder , autism , medicine , broad spectrum , cognition , fragile x , clinical psychology , neuroscience , psychology , psychiatry , pathology , biology , chemistry , combinatorial chemistry , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom